carlisle & Associates
generic drug updates News contact carlisle medical
generic drug updates
Generic Gabitril® Launches
Released: 11/21/2012
By: Mike Partridge, RPh

On October 18, Caraco received final FDA approval and launched the generic equivalent of Teva Pharmaceutical’s branded product Gabitril®. Gabitril® is indicated as adjunctive therapy in adults and children 12 years or older in the treatment of partial seizures.
Note: Gabitril® can also be prescribed to relieve nerve pain and muscle spasticity.

Company News Releases
Generic Drug Updates
Newsletter Subscription
Newsletter Login
© Copyright 2019 Carlisle Medical, Inc.
Twitter Twitter Twitter Twitter
disclaimer site map disclaimer